NetworkNewsBreaks – EVIO, Inc. (EVIO) Launches C
Post# of 2022
(Total Views: 190)
Posted On: 04/19/2018 7:04:38 PM
NetworkNewsBreaks – EVIO, Inc. (EVIO) Launches Canadian Subsidiary, Enters Binding Agreement to Acquire Stake in Cannabis Testing Facility
EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, this morning announced the establishment of a new and wholly-owned subsidiary, EVIO Canada, which will serve as the parent company for EVIO’s Canadian operations. Concurrently, EVIO Canada announced today that it has entered into a binding agreement to acquire 50 percent of Keystone Labs Inc., a privately held, independent contract-testing laboratory specializing in quality testing for regulated industries located in Edmonton, Alberta. “Keystone Labs is one of 37 laboratories licensed by Health Canada and one of only three laboratories that hold both a Dealer’s License and a GMP Drug Establishment License for cannabis testing,” William Waldrop, CEO and co-founder of EVIO, stated in the news release. “This acquisition is a significant milestone for EVIO as it will mark our first foray into an international market. Our goal is to increase consumer safety and confidence, while further pursuing our aggressive expansion plans for 2018.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, this morning announced the establishment of a new and wholly-owned subsidiary, EVIO Canada, which will serve as the parent company for EVIO’s Canadian operations. Concurrently, EVIO Canada announced today that it has entered into a binding agreement to acquire 50 percent of Keystone Labs Inc., a privately held, independent contract-testing laboratory specializing in quality testing for regulated industries located in Edmonton, Alberta. “Keystone Labs is one of 37 laboratories licensed by Health Canada and one of only three laboratories that hold both a Dealer’s License and a GMP Drug Establishment License for cannabis testing,” William Waldrop, CEO and co-founder of EVIO, stated in the news release. “This acquisition is a significant milestone for EVIO as it will mark our first foray into an international market. Our goal is to increase consumer safety and confidence, while further pursuing our aggressive expansion plans for 2018.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)EVIO Inc (EVIO) Stock Research Links
Scroll down for more posts ▼